ISRAEL IN THE TIME OF COVID-19
Time & Location
About the Event
With so many countries working to find an effective vaccine as well as treatments, many people have asked us to find out what vaccine-related research is being done in Israel and how Israeli health professionals are treating those who have become infected with the virus.
On Sunday, December 6 at 11:00 am PT, Dr. David Naveh will moderate a discussion on Israel’s COVID-19 technological response. Dr. Naveh has been involved in drug development and commercialization including Alpha Interferon-Intron, Remicade, Kogenate, Sargomostim, ReoPro, and others in his career in Schering, J&J and Bayer. David led the $700M construction of the Biotech center for Bayer Corp. in Berkeley 4th street. David’s own company, Hemogem, develops blood clotting proteins.
Dr. Shuki Yeshurun is a highly experienced, multidisciplinary scientist and technologies expert. He is a world leader in defense material science. His work integrates both commercial and academic experience. He has brought technology-intensive projects from a concept to the marketplace, and has served as a senior scientist at several Israeli companies, including RAFAEL and the Directorate of Defense Research & Development.
Dr. Yotam Levin is a Medical Advisor to the Israel Biological Institute for the COVID Vaccine Program. Yotam, is the CEO of NanoPass Technologies, a Company that developed the world's smallest needle. He has been involved in about 55 clinical trials, mostly in vaccines (pandemic, seasonal, cancer) and immunotherapies. Dr. Levin holds an MD degree and an MBA (finance), and authored several key publications in leading journals such as the Lancet Infectious Diseases, Vaccine, JID and HV&I, and participated in inventing over two-dozen patent applications.
This is a free event sponsored by the Contra Costa JCC and Cong. Beth Emek.
Important note: You will be receiving a confirmation and a reminder email to the address you provide at check-out. If you don't see these emails in your inbox, please check your spam/junk folders to retrieve them. They will be sent from "email@example.com." Please add this address to your safe sender list.